CODEX multiplexed IF showed that Takinib-treated tumors had increased total and proliferating CD4+ and CD8+ T cells, as well as granzyme B-expressing CD8+ T cells that were physically closer to tumor cells (Fig. 6H). Here, CD4 is linked to neoplasm.